HCPCS Level II code S2112 identifies an arthroscopic surgical procedure of the knee performed specifically to harvest cartilage (chondrocyte cells). This code is relevant nationally as interest in cartilage repair and cell-based therapies grows and as payers refine coverage policies for biologic and regenerative interventions. The procedure is typically performed in ambulatory surgical centers or hospital operating rooms and is distinct from diagnostic or purely therapeutic arthroscopy codes because its primary purpose is tissue procurement for downstream regenerative treatment.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and operative intent, common modifier usage and billing considerations (where available), and how this service aligns with broader trends in orthopedic regenerative care. The publication outlines benchmarks and policy-relevant points such as payer coverage variability, coding specificity for cartilage harvest versus other knee arthroscopy procedures, and the implications for claims processing and documentation. Data not available in the input include associated taxonomies, specific ICD-10 diagnosis pairings, and related codes.